ADVM Stock: Adverum Biotechnologies, Inc. Stock Price, Analysis & Insights

Get live ADVM stock price $4.36, comprehensive Adverum Biotechnologies, Inc. stock analysis, charts, news, and expert forecast. Real-time ADVM stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

4.36

0.00%Today

ADVM • Adverum Biotechnologies, Inc. • NASDAQ Global Market • Healthcare

Market Cap

96.26M

Volume

675.98K

52W High

6.07

52W Low

1.78

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Adverum Biotechnologies, Inc. is a clinical-phase biotechnology firm primarily engaged in discovering and advancing gene therapies. The company's mission is to create innovative treatments for various eye-related conditions and uncommon illnesses. It...

Contact Information

Website: https://www.adverum.com
Address: 800 Saginaw Drive
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Adverum Biotechnologies, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Adverum Biotechnologies, Inc.
⚠Investors should consider how Adverum Biotechnologies, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

96.26M

P/E Ratio (TTM)

-0.51

Beta

0.87

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare ADVM with peer companies:

ALX Oncology Holdings Inc. (ALXO)

Price: $1.57
Market cap: 210.59M

Artiva Biotherapeutics, Inc. (ARTV)

Price: $7.06
Market cap: 174.50M

aTyr Pharma, Inc. (ATYR)

Price: $0.46
Market cap: 44.73M

Biomea Fusion, Inc. (BMEA)

Price: $1.14
Market cap: 67.53M

Precision BioSciences, Inc. (DTIL)

Price: $6.98
Market cap: 89.54M

Fractyl Health, Inc. Common Stock (GUTS)

Price: $0.70
Market cap: 50.79M

Metagenomi, Inc. Common Stock (MGX)

Price: $1.25
Market cap: 47.06M

Pliant Therapeutics, Inc. (PLRX)

Price: $1.18
Market cap: 73.07M

Quince Therapeutics, Inc. (QNCX)

Price: $0.99
Market cap: 5.51M

Sutro Biopharma, Inc. (STRO)

Price: $25.52
Market cap: 246.96M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.